Solid Biosciences Inc at Goldman Sachs Healthcare Conference Transcript
Yeah, it's all been taken up. It's okay, don't worry. All right. Thank you very much. Thank you very much. My name is Bo Cumbo, representing Solid Biosciences. And thank you, Goldman Sachs, for the invitation.
So we're going to be making a few forward-looking statements. Please take time to look at the cautionary note regarding forward-looking statements and take the time to read through it. As you know, this is science. It's hard to predict sometimes. But I'll be doing my best to look forward.
So here'sthepipeline of Solid Biosciences. It's a very robust pipeline. We're going to be up top, Duchenne and FA, followed by amaturing cardiac pipeline that is one of the deepest cardiac pipelines in the gene therapy space. Today, I'm going to be really focused in on Duchenne and FA, and I'll touch a little bit on our platform.
So as mentioning before, we have two programs that are already in the clinic, as well as our capsid platform and manufacturing platform. Our program, our novel next generation
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
